Genus Capital Management »

Gilead Sciences shares owned by Genus Capital Management

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Genus Capital Management from 13F filings

Historical chart of Genus Capital Management investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Genus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Genus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 27k 73.25
2023-12-31 $8.8M 108k 81.01
2023-06-30 $12M 152k 77.07

More positions owned by Genus Capital Management

NVIDIA Corporation Put Option (NVDA)
Merck & Co Put Option (MRK)
Sprouts Fmrs Mkt Put Option (SFM)
Broadcom Put Option (AVGO)
Rbc Cad Put Option (RY)
Acuity Brands Put Option (AYI)
Celestica Put Option (CLS)
Kinross Gold Corp Put Option (KGC)
Ishares Tr Core Us Aggbd Et Put Option (AGG)
NetApp Put Option (NTAP)
Ishares Tr Us Treas Bd Etf Put Option (GOVT)
Alphabet Cap Stk Cl C Put Option (GOOG)
Edwards Lifesciences Put Option (EW)
Apple Put Option (AAPL)
Eli Lilly & Co. Put Option (LLY)

View all positions for Genus Capital Management

Top funds holding Gilead Sciences

BlackRock
Vanguard Group
Capital World Investors
Capital Research Global Investors
State Street Corporation
Dodge & Cox
Geode Capital Management
Wellington Management Company
Morgan Stanley
FMR
Bank of New York Mellon
Northern Trust
Legal & General Group
Dimensional Fund Advisors
Invesco

View all funds holding Gilead Sciences